HPV Vaccine Works for Boys: Study Shows First Clear Benefits (For Pharmacuetical Company Profits)

The vaccine for human papillomavirus (HPV) can prevent 90 percent of genital warts in men when offered before exposure to the four HPV strains covered by the vaccine, according to a new multi-center study led by H. Lee Moffitt Cancer Center and UCSF.

The four-year, international clinical trial, which also found a nearly 66 percent effectiveness in the general population of young men regardless of prior exposure to these strains, provides the first reported results of using the HPV vaccine as a prophylactic in men.

FULL ARTICLE: http://www.sciencedaily.com/releases/2011/02/110204142257.htm
SEE ALSO: India halts HPV vaccine trial after six girls die, US does nothing in response to 67 deaths and counting http://www.naturalnews.com/029632_India_HPV_vaccine.html#ixzz1DUudhr4l

HPV vaccinations are unnecessary and harmful